Abstract

Corneal collagen cross-linking (CXL) has been described as a promising therapy for keratoconus. According to standard CXL protocol, epithelium should be debrided before treatment to allow penetration of riboflavin into the corneal stroma. However, removal of the epithelium can increase procedure risks. In this study we aim to evaluate stromal penetration of a biocompatible riboflavin-based nanoemulsion system (riboflavin-5-phosphate and riboflavin-base) in rabbit corneas with intact epithelium. Two riboflavin nanoemulsions were developed. Transmittance and absorption coefficient were measured on corneas with intact epithelia after 30, 60, 120, 180, and 240 minutes following exposure to either the nanoemulsions or standard 0.1% or 1% riboflavin-dextran solutions. For the nanoemulsions, the epithelium was removed after measurements to assure that the riboflavin had passed through the hydrophobic epithelium and retained within the stroma. Results were compared to de-epithelialized corneas exposed to 0.1% riboflavin solution and to the same riboflavin nanoemulsions for 30 minutes (standard protocol). Mean transmittance and absorption measured in epithelialized corneas receiving the standard 0.1% riboflavin solution did not reach the levels found on the debrided corneas using the standard technique. Neither increasing the time of exposure nor the concentration of the riboflavin solution from 0.1% to 1% improved riboflavin penetration through the epithelium. When using riboflavin-5-phosphate nanoemulsion for 240 minutes, we found no difference between the mean absorption coefficients to the standard cross-linking protocol (p = 0.54). Riboflavin nanoemulsion was able to penetrate the corneal epithelium, achieving, after 240 minutes, greater stromal concentration when compared to debrided corneas with the standard protocol (p = 0.002). The riboflavin-5-phosphate nanoemulsion diffused better into the stroma than the riboflavin-base nanoemulsion.

Highlights

  • Corneal collagen cross-linking (CXL) has emerged as a promising and innovative treatment for progressive keratoconus and surgically-related ectasia [1]

  • ultraviolet A (UVA) radiation decreases as it passes through the cornea, because riboflavin in the cornea absorbs the highest amount of UVA, preventing high doses of this radiation from reaching the posterior ocular structures [36,37]

  • We describe a new option to achieve stromal diffusion of riboflavin without removal of the epithelium and without the use of benzalkoniun chloride

Read more

Summary

Introduction

Corneal collagen cross-linking (CXL) has emerged as a promising and innovative treatment for progressive keratoconus and surgically-related ectasia [1]. De-epithelialization is not risk-free and can increase the rate of corneal infections, haze, scarring, and infiltrates [12,13,14,15,16]. Studies reported the use of benzalkonium chloride (BAK) to loosen tight junctions of corneal epithelial cells and facilitate riboflavin stromal diffusion [9,17]. Both in vitro and in vivo studies have demonstrated adverse effects of BAK on epithelial cell populations [18,19,20,21]. None of the present modalities has proven to be clinically effective in delivering an adequate intrastromal concentration of riboflavin, a better method still needs to be developed

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call